We are committed to researching and developing innovative therapeutic solutions for people around the world by maintaining transparent relationships with stakeholders and patients.

Compliance with laws governing healthcare, professional ethics and our own procedures are the foundations of our activities.

In the US we have fully adopted the Pharmaceutical Research and Manufacturers of America (PhRMA) Code, and adhere to the Sunshine Act aka the National Physician Payment Transparency Program (Open Payments), a section of the Patient Protection and Affordable Care Act of 2010. It requires pharmaceutical and medical device companies report certain payments to the Federal government.

Outside the US, Dompé adheres to applicable laws and regulations.

Learn more about Dompé's commitment to global transparency

Sunshine act

Learn more about the Center for medicare services (CMS) Open Payments a national disclosure program that promotes a transparent and accountable health care system.